New pill aims to strengthen muscles in boys with duchenne
Disease control
Recruiting now
This study tests an oral drug called SAT-3247 in about 51 boys aged 7 to 10 with Duchenne muscular dystrophy (DMD). The goal is to find the best dose and see if it is safe and helps muscle strength. Participants will take the drug or a placebo for 12 weeks, and all will continue …
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC